Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for radiotherapy-related cognitive impairment
NCT03342443Phase 3Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Dec 2017
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in cognitive impairment, sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
memantine
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT03342443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03342443.